Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review
Engaging patients in the process of deprescribing is a necessity. Several patient education materials have been developed for this purpose. The aim of this study was to assess the suitability of the existing patient education materials for proton-pump inhibitors deprescribing.
We conducted a targeted inventory of the available materials on scientific literature and known repositories. We evaluated their suitability with the Suitability Assessment of Materials (SAM) instrument. Materials were rated independently by two researchers and then discussed until consensus was reached.
Seven patient education materials were identified. Three materials (42.9%) were deemed “superior” and 4 (57.1%) were deemed “adequate”. Ratings were generally good in the categories of content, learning stimulation, motivation, typography and layout. The major weaknesses included the use of inappropriate graphics and the too demanding required reading grade level. These may decrease patient attention and comprehension and therefore the effectiveness of education materials.
Suitability of the patient education materials on proton-pump inhibitors deprescribing is overall satisfactory. Greater attention on readability, graphics and inclusion of summaries will be needed for development of future materials.
KeywordsDeprescriptions Proton-pump inhibitors Patient education handout Primary care
We would like to thank Sasha Mann for her help during the language editing of the manuscript.
JN, CR and JPF were involved in the conception of the study. JN was involved in the data collection. JN and JPF were involved in the data analysis. JN and JPF were involved in the data interpretation. JN drafted the first version of the manuscript. JN, CR and JPF read and approved the final manuscript. JN can be contacted for access to the dataset underlying the current analysis.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflict of interest.
- 1.Boghossian TA, Rashid FJ, Thompson W et al (2017) Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011969.pub2
- 3.Furuya-Kanamori L, Stone JC, Clark J, McKenzie S, Yakob L, Paterson DL, Riley TV, Doi SA, Clements AC (2015) Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 36:132–141. https://doi.org/10.1017/ice.2014.39 CrossRefPubMedGoogle Scholar
- 4.Filion KB, Chateau D, Targownik LE, Gershon A, Durand M, Tamim H, Teare GF, Ravani P, Ernst P, Dormuth CR, CNODES Investigators (2014) Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut 63:552–558. https://doi.org/10.1136/gutjnl-2013-304738 CrossRefPubMedGoogle Scholar
- 8.Prescribing & Medicines Team, NHS Digital (2019) Prescription cost analysis - England, 2018. Health and Social Care Information Centre. https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis/2018. Accessed 26 Apr 2019
- 12.Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, Abu-Hanna A (2012) Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 7:e43617. https://doi.org/10.1371/journal.pone.0043617 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Grey matters: a practical tool for searching health-related grey literature (2018). In: Ottawa: CADTH. https://www.cadth.ca/resources/finding-evidence/grey-matters. Accessed 1 Nov 2018
- 16.Doak CC, Doak LG, Root JH (1996) Teaching patients with low literacy skills. https://www.hsph.harvard.edu/healthliteracy/resources/teaching-patients-with-low-literacy-skills/. Accessed 2 Apr 2019CrossRefGoogle Scholar
- 17.Williams AM, Muir KW, Rosdahl JA (2016) Readability of patient education materials in ophthalmology: a single-institution study and systematic review. BMC Ophthalmol:16. https://doi.org/10.1186/s12886-016-0315-0
- 20.Clyne B, Smith SM, Hughes CM, Boland F, Bradley MC, Cooper JA, Fahey T, OPTI-SCRIPT study team (2015) Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: a cluster-randomized controlled trial (OPTI-SCRIPT study). Ann Fam Med 13:545–553. https://doi.org/10.1370/afm.1838 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Pratt NL, Kalisch Ellett LM, Sluggett JK, Gadzhanova SV, Ramsay EN, Kerr M, LeBlanc V, Barratt JD, Roughead EE (2017) Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change. Int J Qual Health Care 29:75–82. https://doi.org/10.1093/intqhc/mzw138 CrossRefPubMedGoogle Scholar
- 23.Vermont Academic Detailing Program (2013) Stopping your proton pump inhibitor or “PPI.” http://contentmanager.med.uvm.edu/docs/default-source/ahec-documents/patienthandoutdiscontinuingppis20130312.pdf?sfvrsn=2. Accessed 1 Apr 2019
- 24.Deprescribing.org, Bruyere Research Institute (2018) Proton pump inhibitor deprescribing guideline information pamphlet. https://deprescribing.org/wp-content/uploads/2018/08/Deprescribing-Pamphlet_PPI_ENG_CFP.pdf. Accessed 1 Apr 2019
- 26.Deprescribing.org, Bruyere Research Institute (2018) Proton pump inhibitor deprescribing infographic. https://deprescribing.org/wp-content/uploads/2018/08/Deprescribing-focus-on-PPIs-FINAL-Mar-7-2018.pdf. Accessed 1 Apr 2019
- 31.Stacey D, Légaré F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001431.pub5